JATHEME Trademark

Trademark Overview

On Tuesday, December 21, 2010, a trademark application was filed for JATHEME with the United States Patent and Trademark Office. The USPTO has given the JATHEME trademark a serial number of 79097714. The federal status of this trademark filing is IR CANCELLED - US APPLICATION ABANDONED as of Monday, December 21, 2020. This trademark is owned by Affymax Pharma Limited. The JATHEME trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke
jatheme

General Information

Serial Number79097714
Word MarkJATHEME
Filing DateTuesday, December 21, 2010
Status402 - IR CANCELLED - US APPLICATION ABANDONED
Status DateMonday, December 21, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 26, 2011

Trademark Statements

Goods and ServicesPharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke
Pseudo MarkJA THEME

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateTuesday, May 8, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAffymax Pharma Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB
Party NameAffymax Pharma Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events

Event DateEvent Description
Sunday, November 14, 2021NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Saturday, November 13, 2021DEATH OF INTERNATIONAL REGISTRATION
Thursday, August 4, 2016ABANDONMENT NOTICE MAILED - INTER PARTES DECISION
Thursday, August 4, 2016NEW REPRESENTATIVE AT IB RECEIVED
Monday, April 21, 2014LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Friday, February 28, 2014LIMITATION OF GOODS RECEIVED FROM IB
Sunday, June 2, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, May 8, 2013FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, May 8, 2013FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sunday, December 9, 2012LIMITATION OF GOODS RECEIVED FROM IB
Tuesday, May 8, 2012ABANDONMENT - AFTER INTER PARTES DECISION
Tuesday, May 8, 2012OPPOSITION TERMINATED NO. 999999
Tuesday, May 8, 2012OPPOSITION SUSTAINED NO. 999999
Saturday, February 11, 2012REFUSAL PROCESSED BY IB
Tuesday, January 24, 2012OPPOSITION INSTITUTED NO. 999999
Monday, January 23, 2012OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Saturday, January 21, 2012OPPOSITION NOTICE (IB REFUSAL) CREATED
Wednesday, August 24, 2011EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, July 26, 2011PUBLISHED FOR OPPOSITION
Wednesday, July 6, 2011NOTICE OF PUBLICATION
Saturday, June 25, 2011APPLICATION FILING RECEIPT MAILED
Thursday, June 23, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 21, 2011ASSIGNED TO EXAMINER
Tuesday, June 21, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, June 17, 2011SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

jatheme failure pharmaceuticals cellular induced degeneration heart stroke hypoxia renal congestive